This site is intended for healthcare professionals only
LoginRegister
Boehringer Ingelheims Vetmedin Becomes First USFDA-Approved Drug to Delay Heart Failure in DogsBoehringer, Click Therapeutics investigational prescription digital therapeutic meets primary...
Health Ministry Reduces Clinical Trial Approval Time from 90 to 45 DaysAbiogenesis Clinpharm To Conduct Phase III Trial of UTI Drug Phenazopyridine
CDSCO Expert Panel Accepts Phase IV Safety Data for Eisai Pharmas Lenvatinib CapsulesLaborate Pharma secures EU-GMP certification, expands global supply chain capabilities
NPPA Clarifies Pharma Data Tender Terms, Technical Presentations on Sept 19Indian pharma market registers 7.9 percent growth in July: Report
Aragen appoints Aniel KhubchandaniAragen appoints Aniel Khubchandani as CEO of Development and Manufacturing Solutions business
Novo Nordisk Loses USD 50 Billion as Obesity Drug Price War Triggers Profit, Sales WarningMounjaro, Wegovy sales in India double on month in July
Eli Lilly in Talks to Acquire Ventyx Biosciences in USD 1 Billion-Plus DealEli Lilly Gets CDSCO Panel Nod for Ixekizumab Safety Label Update
Pill form of Wegovy gets USFDA approval for weight lossCDSCO Panel Approves New Indications for Novo Nordisk's Semaglutide, Mandates PMS Study
Intas PharmaIntas Pharma Gets Expert Panel Nod For PMS Data On Tofacitinib Ointment In Atopic Dermatitis
Axplora invests Euro 6.5 million to expand production capacity at Vizag siteAxplora invests Euro 6.5 million to expand production capacity at Vizag site
Haryana Flags Over 30 Drug Overcharging Cases, Seeks NPPA ActionNPPA Slapped Rs 9,950 Cr Penalty On Pharma Firms, Recovered Only 14.25%
Pfizer files second lawsuit against Metsera, its controlling stockholders, Novo NordiskCureVac announces resolution of patent litigation with Pfizer/BioNTech
X